Gene Therapy against the Progressive Joint Destruction of Rheumatoid Arthritis and Osteoarthritis
Gene Therapy against the Progressive Joint Destruction of Rheumatoid Arthritis and Osteoarthritis
批准号:
13470310
负责人:
SUGAMOTO Kazuomi
金额:
$8.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
类风湿性关节炎(Rheumatoid Arthritis,RA)是一种进行性关节紊乱的慢性炎症性疾病,我国有80多万人患有RA。骨关节炎(Osteoarthritis,OA)也是最常见的全身性疾病之一,随着老年人数量的增加,需要更有效的治疗方法。因此,我们将研究重点放在NFκB对RA和OA发病机制中的炎性细胞因子或蛋白酶的调控上。NFκB在关节炎的发病机制中起重要作用,而诱骗性脱氧核苷酸(decoy deoxynucleotide,ODN)可通过HVJ脂质体基因传递系统抑制NFκB的活化。本研究通过制备类风湿关节炎和骨关节炎动物模型,观察NFκB B圈套ODN对类风湿关节炎和骨关节炎关节破坏的影响。NFκB B decoy ODN通过下调IL-1 β和TNFα的表达,抑制大鼠胶原诱导性关节炎(CIA)的恶化,并证实了NFκB decoy ODN对猴CIA的抑制作用。建立大鼠前交叉韧带横断(ACLT)的OA模型。NFκB decoy ODN对实验性关节炎也有一定的治疗作用。结论:针对NFκB的诱骗策略是治疗RA和OA的有效方法。NFκB B诱骗ODN在类风湿关节炎中的临床应用有待进一步研究。
英文摘要
Rheumatoid Arthritis(RA) is a chronic inflammatory disease with the progressive joint distraction, from which more than eight hundred thousands people are suffered in our country. Osteoarthritis(OA) is also one of the most common general disease, and the more effective therapy should be needed when the number of the elderly people will increase in the near future. So we focused on NFκB to modulate the inflammatory cytokines or proteinase which are involved in the pathogenesis of RA and OA. We have already reported that NFκB plays an important role in a regulation of arthritis and decoy deoxynucleotide(ODN) can suppress the activation of NFκB by our original gene delivery system with HVJ-lipoisome. In This investigation, we prepared the experimental animal model of RA and OA to evaluate the efficacy of NFκB decoy ODN against the joint destruction of these arthritis. We showed NFκB decoy ODN suppressed the deterioration of collagen-induced arthritis(CIA) in rats via down-regulation of IL-Iβ and TNFα, and also confirmed the same results with CIA in monkeys. As the OA model, we established the rats with anterior cruciate ligament transection(ACLT). NFκB decoy ODN was also effective to the experimental arthritis. We concluded That the decoy strategy against NFκB is an effective therapeutic candidate for RA and OA. The clinical application of NFκB decoy ODN to the joints of RA patients will be following after these our results.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nakase T, Tomita T, et al.: "Involvement of BMP-2 signaling in a cartilage cap in osteochondroma"J Orthop Res. 19. 1085-1088 (2001)
Nakase T、Tomita T 等人:“骨软骨瘤软骨帽中 BMP-2 信号传导的参与”J Orthop Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tomita T, et al.: "Differentiation of monocytes into multinucleated giant bone-resorbing cells : two-step differentiation induced by nurse-like"Arthritis Res.. 3. 306-310 (2001)
Tomita T等人:“单核细胞分化为多核巨型骨吸收细胞:护士样诱导的两步分化”Arthritis Res.. 3. 306-310 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakase T, Miyaji T, Kuriyama K, Tamai N, Horiki M, Tomita T, Myoui A, Shimada K, Yoshikawa H.: "Immunohistochemical detection of parathyroid hormone-related peptide. Indian hedgehog, and patched in the process of endochondral ossification in the human."Hi
Nakase T、Miyaji T、Kuriyama K、Tamai N、Horiki M、Tomita T、Myoui A、Shimada K、Yoshikawa H.:“甲状旁腺激素相关肽的免疫组织化学检测。印度刺猬,以及软骨内骨化过程中的补丁”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka S, Tomita T, Yoshikawa H. et al.: "Novel autoantibodies to pituitary gland specific factor 1a in patients with rheumatoid arthritis"Rheumatology. 42(2). 353-356 (2003)
Tanaka S、Tomita T、Yoshikawa H. 等人:“类风湿性关节炎患者垂体特异性因子 1a 的新型自身抗体”风湿病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tomita T, Nakase T, Yoshikawa H. et al.: "Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis"Arthritis Rheum. 46(2). 373-378 (2002)
Tomita T、Nakase T、Yoshikawa H.等人:“类风湿性关节炎中细胞外基质金属蛋白酶诱导物的表达和基质金属蛋白酶产生的增强”关节炎大黄。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Construction of a data base for 3D kinematics of all motion of all human joints.
-
批准号:22300204
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.65万
-
财政年份:2010
-
负责人:SUGAMOTO Kazuomi
-
依托单位:
海外基金